Advisory: Incorrect revenue alert on Shanghai Henlius Biotech withdrawn
03/12/2025 14:40
Dec 3 (Reuters) - An incorrect revenue alert on Shanghai Henlius Biotech 2696.HK inadvertently triggered from an announcement of a distribution framework agreement has been withdrawn. There will be no replacement for the alert. STORY_NUMBER:PLX4A35EA STORY_DATE:03/12/2025 STORY_TIME:[01:51:30] ((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Shanghai Henlius Biotech
See all newsBrief: Shanghai Henlius Biotech Says Wenjie Zhang Resigns As Chairman
Brief: Shanghai Henlius Biotech Enters Collaboration And License Agreement With Amberstone Biosciences
Brief: Shanghai Henlius Biotech Says NDA For 120 Mg Biosimilar Denosumab HLX14 Accepted By NMPA
China's Henlius H1 revenue jumps on drug sales, license income
Brief: Shanghai Henlius Biotech Logs HY Profit RMB 430.4 Mln